[MCEMENT] QoQ TTM Result on 31-Mar-2012 [#1]

Stock
[MCEMENT] MALAYAN CEMENT BERHAD
Announcement Date
29-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 4.04%
YoY- 10.51%
Quarter Report
Latest QR
Upcoming QR
MCEMENT's Result
MCEMENT's Financial Summary
View:
Show?
TTM Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 2,740,062 2,706,767 2,623,539 2,593,991 2,552,564 2,512,897 2,455,461 7.54%
PBT 469,752 475,336 439,193 432,899 414,647 364,963 369,891 17.18%
Tax -120,262 -113,818 -102,375 -101,245 -97,000 -86,105 -72,953 39.33%
NP 349,490 361,518 336,818 331,654 317,647 278,858 296,938 11.42%
-
NP to SH 349,003 360,667 335,597 330,699 317,845 280,972 300,818 10.36%
-
Tax Rate 25.60% 23.94% 23.31% 23.39% 23.39% 23.59% 19.72% -
Total Cost 2,390,572 2,345,249 2,286,721 2,262,337 2,234,917 2,234,039 2,158,523 7.01%
-
Net Worth 3,180,186 3,135,374 3,101,386 3,092,889 3,113,280 3,064,288 3,053,867 2.72%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 314,764 288,989 288,920 288,808 288,979 288,667 288,909 5.85%
Div Payout % 90.19% 80.13% 86.09% 87.33% 90.92% 102.74% 96.04% -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 3,180,186 3,135,374 3,101,386 3,092,889 3,113,280 3,064,288 3,053,867 2.72%
NOSH 849,695 849,695 849,695 849,695 850,623 848,833 848,296 0.10%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 12.75% 13.36% 12.84% 12.79% 12.44% 11.10% 12.09% -
ROE 10.97% 11.50% 10.82% 10.69% 10.21% 9.17% 9.85% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 321.38 318.56 308.76 305.28 300.08 296.04 289.46 7.18%
EPS 40.93 42.45 39.50 38.92 37.37 33.10 35.46 9.98%
DPS 37.00 34.00 34.00 34.00 34.00 34.00 34.00 5.77%
NAPS 3.73 3.69 3.65 3.64 3.66 3.61 3.60 2.38%
Adjusted Per Share Value based on latest NOSH - 849,695
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 205.57 203.07 196.83 194.61 191.50 188.53 184.22 7.54%
EPS 26.18 27.06 25.18 24.81 23.85 21.08 22.57 10.34%
DPS 23.61 21.68 21.68 21.67 21.68 21.66 21.68 5.82%
NAPS 2.3859 2.3523 2.3268 2.3204 2.3357 2.299 2.2911 2.72%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 9.62 8.90 7.30 7.20 7.00 6.56 7.45 -
P/RPS 2.99 2.79 2.36 2.36 2.33 2.22 2.57 10.56%
P/EPS 23.50 20.97 18.48 18.50 18.73 19.82 21.01 7.71%
EY 4.26 4.77 5.41 5.41 5.34 5.05 4.76 -7.10%
DY 3.85 3.82 4.66 4.72 4.86 5.18 4.56 -10.62%
P/NAPS 2.58 2.41 2.00 1.98 1.91 1.82 2.07 15.73%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 20/02/13 22/11/12 28/08/12 29/05/12 22/02/12 22/11/11 24/08/11 -
Price 9.19 9.62 8.60 7.07 7.37 6.59 7.01 -
P/RPS 2.86 3.02 2.79 2.32 2.46 2.23 2.42 11.72%
P/EPS 22.45 22.66 21.77 18.17 19.72 19.91 19.77 8.80%
EY 4.45 4.41 4.59 5.50 5.07 5.02 5.06 -8.17%
DY 4.03 3.53 3.95 4.81 4.61 5.16 4.85 -11.56%
P/NAPS 2.46 2.61 2.36 1.94 2.01 1.83 1.95 16.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment